Autosomal –dominant epidermodysplasia verruciformisun satisfactorily treated with ingenol mebutate: a case report

Jelica Vukicevic
DOI: https://doi.org/10.15406/jdc.2021.05.00196
2021-12-24
Journal of Dermatology & Cosmetology
Abstract:Background: Epidermodysplasia verruciformis (EV) is a rare, usually autosomal-recessive inherited disorder characterised by development of flat wartsortinea versicolor-like lesions on sun exposed area caused byspecific human papillomavirusis (HPVs). Several nonsurgical treatment modalities were tried with temporary results, but successful treatment of EV with ingenol mebutate (Picato) has been reported recently. In this case, autosomal-dominant EV unsatisfactorily treated with ingenol mebutate is shown. Case: A 58-year-old woman with EV was unsuccessfully treated with traditional therapeutical modalities. Ingenol mebutate (0,5%) was administered for 2 days and a significant improvement in lesion reduction was achieved. However, after 2 months there was a recurrence with the appearance of new lesions and an increase of existing ones. Conclusion: This report is another confirmation that EV remains a therapeutic challenge.
What problem does this paper attempt to address?